One Year.
One CGM.
Eversense 365 is the only ONE YEAR CGM, reducing device burden so patients can manage diabetes, not a device.
A patient experience with less device burden and more confidence1
86% reported less day-to-day burden
compared to their previous CGM2.
86% reported less day-to-day burden compared to their previous CGM2.
No wasting CGMs with knock offs.
Because the sensor is implanted, knocking the transmitter off won’t waste a CGM.
No more frequent sensor changes.
One sensor placement per year means less disruption and fewer requests for extra CGMs.
No more skin reactions.
A gentle silicone-based adhesive is changed daily and causes almost no skin irritation.1
Accurate & reliable data.
Exceptional accuracy for one year.3,5
Consistent glucose data patients and clinicians can rely on over time.
How it Works
Images are for illustration and may not show actual proportions of system components.
Watch How it Works
An affordable option for patients
Eversense 365 is covered by most commercial insurance plans and Medicare for those using insulin. Eversense PASS® Programs can help eligible patients save on the device.
Now connects with the twiist™ Automated Insulin Delivery System
Patients get continuous glucose monitoring and precise automated insulin delivery in one connected experience4.
The pump can make automatic adjustments to basal insulin delivery based on real-time glucose readings and personal settings, helping to maintain glucose levels within a target range4.
Start Patients in 3 Easy Steps With End-to-End Support
Prescribe Eversense 365 for your patient.
Let the Eversense Inserter Network manage the insertion process for you.
Continue your patient care and monitor their progress with DMS Pro.
Talk to an Eversense Expert to learn more or to get your patients started
"*" indicates required fields
By clicking 'Submit' you confirm that you are allowed to provide this information and that you have carefully read our Privacy Policy and understood how we may process your health-related information. By clicking submit you consent to being contacted by Senseonics or our trusted partners.
Do You Have Questions?
* There is no glucose data generated when the transmitter is removed
1. Tweden, K. S. et al. (2024). Long-term Safety and People Reported Outcomes of a Long-Duration Implantable CGM System in the US Post Approval Setting. Interventions Obes Diabetes, 6(5), IOD. 000648. 2024. DOI: 10.31031/IOD.2024.06.000648
2. Barnard KD, et al. Acceptability of implantable continuous glucose monitoring sensor. Journal of Diabetes Science and Technology 2018;12(3):634-638.
3. Senseonics. (2026) Eversense 365 Continuous Glucose Monitoring System User Guide. LBL-7702-01-001
4. Sequel Med Tech - twiist Automated Insulin Delivery (AID) System Powered by Tidepool User Guide
twiist Automated Insulin Delivery (AID) System is for people with type 1 diabetes, 6 years of age and above, available with a prescription, only in the U.S. Visit twiist.com/safety for important safety information.
5. Bailey TS, et.al., Evaluation of Accuracy and Safety of the 365-Day Implantable Eversense Continuous Glucose Monitoring System: The ENHANCE Study. Diabetes Technology & Therapeutics, 2025 Jan 27. doi: 10.1089 / dia. 2024.0592.
© 2026 Senseonics, Incorporated.
All rights reserved.
20451 Seneca Meadows Parkway
Germantown, MD 20876-7005 USA
844-SENSE4U (736-7348)
eversensecgm.com
Eversense, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. Other brands and their products are trademarks or registered trademarks of their respective holders and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a healthcare provider. The Eversense 365 CGM System is a prescription device; patients should talk to their healthcare provider to learn more.
For safety information, see bit.ly/eversensesafety